Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer

AIM: Some retrospective studies have shown a lack of benefit of 5‐fluorouracil (5‐FU) adjuvant chemotherapy in patients with mismatch repair (MMR) deficient colorectal cancer. Our aim was to assess if this molecular marker can predict benefit from 5‐FU adjuvant chemotherapy. A second objective was t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jover, R, Zapater, P, Castells, A, Llor, X, Andreu, M, Cubiella, J, Piñol, V, Xicola, R M, Bujanda, L, Reñé, J M, Clofent, J, Bessa, X, Morillas, J D, Nicolás‐Pérez, D, Payá, A, Alenda, C
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2006
Assuntos:
Colorectal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1856227/
https://ncbi.nlm.nih.gov/pubmed/16299036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.073015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados